Leo Ehrlich
Förmögenhet: 8 668 $ per 2026-07-31
Förmögenhet: 8 668 $ per 2026-07-31
Mr. Leo Ehrlich, CPA, is a Chairman, CEO, Chief Financial Officer & Secretary at Innovation Pharmaceuticals, Inc. Mr. Ehrlich was previously employed as a Chief Financial Officer by Cellceutix Pharma, Inc., a Chief Financial Officer by NanoViricides, Inc. /Old/, a President, CEO, COO, CFO, Secretary & Director by StatSure Diagnostic Systems, Inc., and a Chief Financial Officer & Director by NanoViricides, Inc. He received his undergraduate degree from Baruch College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2023-09-28 | 4 333 936 ( -.--% ) | 8 668 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| INNOVATION PHARMACEUTICALS INC. | Verkställande Direktör | 2010-11-05 |
| Företag | Position | Slut |
|---|---|---|
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Finansdirektör/CFO | 2007-12-06 |
| NANOVIRICIDES, INC. | Finansdirektör/CFO | 2007-05-16 |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Finansdirektör/CFO | 2007-05-01 |
| STATSURE DIAGNOSTIC SYSTEMS, INC. | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
StatSure Diagnostic Systems, Inc.
StatSure Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical specimen collection devices for the rapid tests of infectious diseases | Health Technology |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
NanoViricides, Inc.
NanoViricides, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes anti-viral therapeutics | Health Technology |
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Health Technology |
Innovation Pharmaceuticals, Inc.
Innovation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån